Live Free or Die Legal
This website is not an official source of law. This website does not provide legal advice. For official legal materials, verify against the relevant court, legislature, agency, or other official source. Legal information may be incomplete, outdated, or incorrectly processed. Consult a qualified attorney for advice about a specific legal matter.

This RSA section is an unofficial mirror, is not legal advice, and may be incomplete, outdated, or incorrectly processed.

RSA 350-B:7 · Effect on Other Law

Title
XXXI: TRADE AND COMMERCE
Chapter
350-B · UNIFORM TRADE SECRETS ACT
Status
current
Official source linked
Yes
Official source Copy section link

350-B:7 Effect on Other Law. –

Copy link
I.

Except as provided in paragraph II, this chapter displaces conflicting tort, restitutionary, and other law of this state providing civil remedies for misappropriation of a trade secret.

Copy link
II.

This chapter shall not affect:

Copy link
(a)

Contractual remedies, whether or not based upon misappropriation of a trade secret;

Copy link
(b)

Other civil remedies that are not based upon misappropriation of a trade secret; or

Copy link
(c)

Criminal remedies, whether or not based upon misappropriation of a trade secret. Source. 1989, 220:1, eff. Jan. 1, 1990.

Copy link

Source note

Source. 1989, 220:1, eff. Jan. 1, 1990.

Source history

  • 1989, 220:1, eff. Jan. 1, 1990

Related materials

Bill relationships

  • 2026 SB547 reference · effective 2026-10-01

    ecessary to promote transparency, support competitive markets, and inform decision-making by state policymakers. Reports meeting these standards shall not be considered to violate RSA 350-B, the uniform trade secrets act, even if they provide summary information at the level of individual pharmacy benefit managers and allow comparisons to be made between pharmacy benefit managers. 5 Severability Clause.

  • 2026 SB547-FN reference · effective 2026-10-01

    ecessary to promote transparency, support competitive markets, and inform decision-making by state policymakers. Reports meeting these standards shall not be considered to violate RSA 350-B, the uniform trade secrets act, even if they provide summary information at the level of individual pharmacy benefit managers and allow comparisons to be made between pharmacy benefit managers. 5 Severability Clause.

Opinions and discipline decisions mentioning this RSA